The Gureater drug-eluting stent has a cobalt chromium (CoCr) platform and a bioasorbable polymer (PLGA) that allows early endolethalization, thus avoiding inflammation. Combined with the drug Sirolimus, it has excellent release control over a total period of 90 days. Its design provides super-flexibility, optimum crossing capacity and low recoil rate.

CoCr drug-eluting stent
75 um strut thickness
Low recoil rate
Biodegradable (or bioabsorbable) PLGA polymer
Sirolimus effective drug
90-day drug release period
Compatible with magnetic resonance imaging

good post-stent performance
good drug release control;
prevents inflammation caused by durable polymer
better endothelialization